These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2372337)

  • 1. Icteric serum as an indicator of fetal vascular access during intravascular transfusion for hemolytic disease.
    Moise KJ; Kirshon B; Carpenter RJ; Deter RL
    Am J Perinatol; 1990 Jul; 7(3):279-80. PubMed ID: 2372337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of serial intravascular transfusions in ascitic/hydropic RhD-alloimmunized fetuses.
    Craparo FJ; Bonati F; Gementi P; Nicolini U
    Ultrasound Obstet Gynecol; 2005 Feb; 25(2):144-8. PubMed ID: 15660441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
    Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
    Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal hydrops and other variables associated with the fetal hematocrit decrease after the first intrauterine transfusion for red cell alloimmunization.
    Lobato G; Soncini CS
    Fetal Diagn Ther; 2008; 24(4):349-52. PubMed ID: 18849608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonimmune hydrops caused by massive fetomaternal hemorrhage and treated by intravascular transfusion.
    Thorp JA; Cohen GR; Yeast JD; Perryman D; Welsh C; Honssinger N; Stephenson S; Hedrick J
    Am J Perinatol; 1992 Jan; 9(1):22-4. PubMed ID: 1550627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nomograms for rapid estimation of intravascular intrauterine exchange transfusion.
    Christmas JT; Little BB; Johnston WL; Santos-Ramos R; Theriot SK; Brown CE
    Obstet Gynecol; 1990 May; 75(5):887-91. PubMed ID: 2325972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In utero exchange transfusion by direct intravascular injection in severe erythroblastosis fetalis.
    Grannum PA; Copel JA; Plaxe SC; Scioscia AL; Hobbins JC
    N Engl J Med; 1986 May; 314(22):1431-4. PubMed ID: 3702951
    [No Abstract]   [Full Text] [Related]  

  • 8. Donor blood glucose 6-phosphate dehydrogenase deficiency reduces the efficacy of exchange transfusion in neonatal hyperbilirubinemia.
    Samanta S; Kumar P; Kishore SS; Garewal G; Narang A
    Pediatrics; 2009 Jan; 123(1):e96-e100. PubMed ID: 19103674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Indications for exchange transfusion independent of the bilirubin levels in the newborn with hemolytic diseases].
    de Almeida JM
    Rev Port Pediatr Pueric; 1969; 32(3):77-86. PubMed ID: 5817830
    [No Abstract]   [Full Text] [Related]  

  • 10. Albumin and packed red blood cells in the treatment of severely isoimmunised pregnancies.
    Marianowski L; Debski R; Rokicki T; Pasek K; Lukaszewicz E; Gromadzki J
    Mater Med Pol; 1992; 24(4):260-1. PubMed ID: 1308057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful intrauterine treatment of fetal hydrops caused by parvovirus B19 infection.
    Gloning KP; Schramm T; Brusis E; Schwarz T; Roggendorf M
    Behring Inst Mitt; 1990 Aug; (85):79-85. PubMed ID: 2171492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct relationship of fetal carboxyhemoglobin with hemolysis in alloimmunized pregnancies.
    Widness JA; Lowe LS; Stevenson DK; Vreman HJ; Weiner CP; Hayde M; Pollak A
    Pediatr Res; 1994 Jun; 35(6):713-9. PubMed ID: 7936824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetraploid mixoploidy presenting as refractory hydrops in a case of immune hemolytic anemia.
    Dadhwal V; Deka D; Sharma A; Sharma Y; Bahadur A
    Prenat Diagn; 2007 Dec; 27(13):1262. PubMed ID: 17994636
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of non-immune hydrops: 8 years' experience.
    Anandakumar C; Biswas A; Wong YC; Chia D; Annapoorna V; Arulkumaran S; Ratnam S
    Ultrasound Obstet Gynecol; 1996 Sep; 8(3):196-200. PubMed ID: 8915090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemolytic disease of the newborn due to Rh factor. Immediate exchange transfusion].
    Pérez Murphy L; Rodríguez Mateos O; Zárate Sandoval H; Torres Ruvalcaba AB; Bailón Uriza R
    Ginecol Obstet Mex; 1970 May; 27(163):575-85. PubMed ID: 5482729
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness of single versus double volume exchange transfusion in newborn infants with AB0 hemolytic disease.
    Amato M; Blumberg A; Hermann U; Zurbrügg R
    Helv Paediatr Acta; 1988 Nov; 43(3):177-86. PubMed ID: 3220789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on fetal physiology and pathophysiology in rhesus disease.
    Nicolaides KH
    Semin Perinatol; 1989 Aug; 13(4):328-37. PubMed ID: 2528210
    [No Abstract]   [Full Text] [Related]  

  • 18. [Quantitative analysis of bilirubin by direct spectrophotometry of serum of newborns. A micromethod independent of possible hemolysis].
    Sudmann E
    Nord Med; 1969 Oct; 82(41):1292-5. PubMed ID: 4982177
    [No Abstract]   [Full Text] [Related]  

  • 19. In utero erythrocyte transfusion for fetal xerocytosis associated with severe anemia and non-immune hydrops fetalis.
    Ogburn PL; Ramin KD; Danilenko-Dixon D; Fairbanks VF; Ramsey PS
    Am J Obstet Gynecol; 2001 Jul; 185(1):238-9. PubMed ID: 11483935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of fetal hydrops due to maternal antibodies against a low incidence paternal red cell antigen: a novel insight from clinical practice.
    Hills A; Massey E; Search S; Poole J; Jones SW; Moppett J; Overton T
    Fetal Diagn Ther; 2013; 33(2):137-40. PubMed ID: 23257662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.